Psychedelics Optimi Health secures MDMA and psilocybin distribution agreement in Australia The company will supply Mind Medicine Australia with the substances, now considered designated therapies in the country Rowan DunneMarch 1, 2023
International Mind Medicine Australia receives AUD$1M grant for psychedelic research New fund will support studies on psychedelic-assisted therapies for the treatment of mental health conditions Rowan DunneAugust 23, 2022
Industry update Australia to spend $14.5M on psychedelic drug trials Australia is funding research to see if magic mushrooms and ecstasy can treat depression and PTSD Jared GnamMarch 17, 2021